Shilpa Medicare informs about disclosure

23 Jan 2025 Evaluate
Shilpa Medicare has informed that the company’s 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Teriflunomide.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

641.05 17.35 (2.78%)
05-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1581.95
Dr. Reddys Lab 1126.55
Cipla 1418.45
Lupin 2009.65
Zydus Lifesciences 887.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...